PRISM Race and Communication Pilot RCT (NCT04915079) | Clinical Trial Compass
CompletedPhase 1/2
PRISM Race and Communication Pilot RCT
United States28 participantsStarted 2023-07-19
Plain-language summary
This is a pilot randomized trial of 60 patients to test feasibility, acceptability and efficacy of PRISM to improve resilience and facilitate improved patient-clinician communication in racially minorities patients with serious illness.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Seriously ill adults with median life expectancy of two years or less (e.g. metastatic cancer or inoperable lung cancer, chronic obstructive pulmonary disease (COPD) with forced expiratory volume in 1 second (FEV1) \<35% predicted or oxygen dependence, restrictive lung disease with total lung capacity (TLC) \<50% predicted, New York Heart Association (NYHA) class III or IV heart failure, or Child's class C cirrhosis or Model for End Stage Liver Disease(MELD) \>17)
* Hospitalized at either Harborview Medical Center or University of Washington Medical Center-Montlake
* At least 18 years of age
* English-speaking
* No cognitive impairment precluding completion of surveys or participation in the PRISM sessions
Exclusion Criteria:
* Younger than 18 years of age
* Non-English speaking
* Ccgnitive impairment that would preclude completion of surveys and participation in the PRISM sessions.